Novelix Pharmaceuticals Limited (BOM:536565)

Market Cap	1.49B +180.5%
Revenue (ttm)	1.32B +330.6%
Net Income	25.57M +2,924.8%
EPS	1.21 +1,244.4%
Shares Out	21.09M
PE Ratio	58.51
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,203
Open	70.00
Previous Close	67.43
Day's Range	70.00 - 70.80
52-Week Range	38.00 - 92.00
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Novelix Pharmaceuticals

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Employees: 8
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 536565

Financial Performance

In fiscal year 2026, Novelix Pharmaceuticals's revenue was 1.32 billion, an increase of 330.60% compared to the previous year's 307.33 million. Earnings were 25.57 million, an increase of 2924.85%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 5, 2026

Data Sources Report a data error